These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23768568)

  • 1. [Osteoporosis fracture in a male patient secondary to hypogonadism due to androgen deprivation treatment for prostate cancer].
    Verdú Solans J; Roig Grau I; Almirall Banqué C
    Semergen; 2014; 40(4):e73-6. PubMed ID: 23768568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporosis in men treated with androgen deprivation therapy for prostate cancer.
    Ross RW; Small EJ
    J Urol; 2002 May; 167(5):1952-6. PubMed ID: 11956415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of bisphosphonates in men with prostate cancer receiving androgen deprivation therapy.
    Smith MR
    Oncology (Williston Park); 2004 May; 18(5 Suppl 3):21-5. PubMed ID: 15202584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis and prostate cancer: a cross-sectional study of Danish men with prostate cancer before androgen deprivation therapy.
    Poulsen MH; Frost M; Abrahamsen B; Brixen K; Walter S
    Scand J Urol; 2014 Aug; 48(4):350-5. PubMed ID: 24548220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive osteoporosis during androgen deprivation therapy for prostate cancer.
    Daniell HW; Dunn SR; Ferguson DW; Lomas G; Niazi Z; Stratte PT
    J Urol; 2000 Jan; 163(1):181-6. PubMed ID: 10604342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Androgen deprivation therapy for prostate cancer and osteoporotic risk].
    Cortet B; Lartigau E; Caty A; Moulinier F; Staerman F; Villamizar-Vesga J; Villers A
    Prog Urol; 2012 Sep; 22 Suppl 2():S31-8. PubMed ID: 23098788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer, osteoporosis and fracture risk.
    Allain TJ
    Gerontology; 2006; 52(2):107-10. PubMed ID: 16508318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy.
    Krupski TL; Smith MR; Lee WC; Pashos CL; Brandman J; Wang Q; Botteman M; Litwin MS
    Cancer; 2004 Aug; 101(3):541-9. PubMed ID: 15274067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment effect of breast cancer and prostate cancer on bone].
    Varsavsky M; Guadalix Iglesias S
    Med Clin (Barc); 2013 Feb; 140(4):164-8. PubMed ID: 22841464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of osteoporosis--important for the urologist?].
    Lümmen G; Rübben H; Schneider T; Sperling H
    Urologe A; 2007 Jun; 46(6):651-5. PubMed ID: 17453170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone, bone and osteoporosis.
    Tuck S; Francis R
    Front Horm Res; 2009; 37():123-132. PubMed ID: 19011293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: a matched cohort study of 19,079 men.
    Alibhai SM; Duong-Hua M; Cheung AM; Sutradhar R; Warde P; Fleshner NE; Paszat L
    J Urol; 2010 Sep; 184(3):918-23. PubMed ID: 20643458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic and cardiovascular effects of androgen deprivation therapy.
    Hakimian P; Blute M; Kashanian J; Chan S; Silver D; Shabsigh R
    BJU Int; 2008 Dec; 102(11):1509-14. PubMed ID: 18727614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone loss in men under androgen-deprivation therapy for prostate cancer].
    Ishizaka K; Machida T; Yoshida K
    Nihon Rinsho; 2005 Apr; 63(4):721-6. PubMed ID: 15828242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Osteoporosis in men].
    Biver E; Uebelhart B
    Rev Med Suisse; 2013 Jun; 9(390):1260-4. PubMed ID: 23821844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case of progressive prostatic carcinoma in a patient with acquired hypogonadism].
    Inahara M; Yamazaki K; Ishida Y; Kojima S
    Hinyokika Kiyo; 2010 Apr; 56(4):241-4. PubMed ID: 20448451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of osteoporotic fractures in patients treated by androgen blockade for prostate cancer].
    Dahmani L; Wagner B; Auzanneau C; Irani J; Doré B
    Prog Urol; 2003 Feb; 13(1):73-8. PubMed ID: 12703357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of male osteoporosis and prostate cancer.
    Gilbert SM; McKiernan JM
    Curr Opin Urol; 2005 Jan; 15(1):23-7. PubMed ID: 15586025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer treatment-induced bone loss.
    Adler RA
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):442-5. PubMed ID: 17982349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Osteoporosis in castration therapy--a neglected field].
    Bratt O; Akesson K
    Lakartidningen; 2011 Sep 28-Oct 4; 108(39):1902-5. PubMed ID: 22111227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.